NCT04305444 2025-01-08Study of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's LymphomasZhejiang DTRM BiopharmaPhase 2 Terminated55 enrolled
NCT01022996 2016-05-18Study of RAD001 in Patients With Relapsed/Refractory Hodgkin Lymphoma That Has Progressed After High-dose Chemotherapy and Autologous Stem Cell Transplant and/or After Gemcitabine- or Vinorelbine- or Vinblastine-based Treatment.NovartisPhase 2 Completed57 enrolled 10 charts